Sorrento Therapeutics Investors
Sorrento Therapeutics is a private equity firm headquartered in San Diego, California, established in 2006 The firm specializes in the development and commercialization of innovative biopharmaceutical products Sorrento Therapeutics focuses on advancing therapies in oncology, immunology, and pain management, leveraging its proprietary technologies The firm has engaged in significant investments, with a notable scale of approximately $30,000,000, to support its strategic initiatives and research endeavors Sorrento Therapeutics is committed to addressing unmet medical needs through its robust pipeline and collaborative partnerships
Acquisitions Number:
Made Acquisitions
Founded Date:
2006
Last Funding Type:
Post-IPO Equity
Headquarters:
USA
Investors Number:
1
Technology:
Others
Employee Number:
101-250
Industry:
FemTech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-10-09
Number Of Exists:
N/A
Funding Status:
IPO
Investor Type:
Private Equity Firms
Investment Stage:
N/A
Total Funding:
264418495.0